Print

Bruker Corporation Announces European Launch of Toxtyper™, a Novel Clinical Mass Spectrometry Screening Solution for Toxicology  
9/26/2012 8:37:39 AM

MANNHEIM, Germany--(BUSINESS WIRE)--At the annual conference of the DGKL (Deutsche Vereinte Gesellschaft für Klinische Chemie und Laboratoriumsmedizin –see www.dgkl.de), Bruker today announced the European launch of the novel, automated Toxtyper™ clinical mass spectrometry solution to meet the increasing demands for LC-MS/MS throughput and data quality in routine toxicology laboratories without the need for mass spectrometry expertise. The Toxtyper solution provides faster and more reliable identification of toxins and drugs of abuse within 10 minutes at therapeutic and toxic levels. Bruker developed the Toxtyper solution with a library of 850 compounds in close collaboration with Jürgen Kempf at the Institute of Forensic Medicine in Freiburg, Germany, and with Professor Denis Hochstrasser and Dr. Marc Fathi’s team at the Geneva University Hospital (HUG - Hôpitaux Universitaires de Genève) in Switzerland.
//-->